查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1998352

獸醫參考實驗室市場：按動物種類、檢測類型、技術、檢體類型、最終用戶和疾病類型分類－2026年至2032年全球市場預測

Veterinary Reference Laboratory Market by Animal Type, Test Type, Technology, Sample Type, End User, Disease Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸醫參考實驗室市場價值將達到 47.6 億美元，到 2026 年將成長到 50.3 億美元，到 2032 年將達到 77.5 億美元，年複合成長率為 7.21%。

主要市場統計數據
基準年 2025 47.6億美元
預計年份：2026年 50.3億美元
預測年份 2032 77.5億美元
複合年成長率 (%) 7.21%

本文概述了技術進步、監管趨勢和營運壓力如何重新定義獸醫參考實驗室的優先事項。

本導言概述了快速發展的獸醫診斷領域，其中技術創新、不斷變化的監管重點和動物健康的變化相互交織，重塑檢查室運作和臨床決策。

對技術、監管和供應鏈因素相互交織的格局進行權威分析，這些因素正在加速整個獸醫診斷服務領域的結構性變化。

本節檢驗了正在重塑獸醫診斷服務的變革性變化，重點介紹了技術進步、政策轉變和不斷變化的相關人員期望如何加速該領域的成熟。

詳細分析美國近期關稅調整對診斷檢查室採購、供應鏈韌性和營運規劃的影響。

本分析探討了近期美國關稅變化對獸醫診斷業務、供應鏈和籌資策略的累積影響，同時對營運實際情況和風險緩解措施保持平衡的觀點。

以細分為導向的全面觀點動物類別、診斷方法、技術平台、終端用戶需求、優先疾病和檢體類型與檢查室策略聯繫起來。

基於細分的洞察揭示了診斷需求和檢查室設計在不同動物種類、檢測方法、技術平台、終端用戶類型、優先疾病和檢體流方面的差異，從而為產品組合和產能規劃提供了詳細的藍圖。

一項精細的區域分析突顯了監管多樣性、臨床引入模式和供應鏈結構如何對世界各地的檢查室運作產生獨特的影響。

區域模式凸顯了監管、供應和臨床實踐環境的差異，這些差異會影響世界各地市場的檢查室營運和策略定位。

對產業參與者所採取的策略立場進行了深入的概述，涵蓋了從垂直整合平台到專業服務供應商和協作創新模式等各個方面。

主要企業的競爭行為表明，在垂直整合、服務廣度和夥伴關係模式方面的策略選擇如何在診斷生態系統中創造差異化的價值提案。

為檢查室經營團隊提供確保長期運作韌性的實用指導。重點在於人才敏捷性、採購韌性、模組化技術應用和基於證據的夥伴關係。

透過切實可行的建議，本資源指南檢查室經營團隊和產業領導者優先考慮投資、培養人才和製定供應商策略，以增強韌性和臨床意義。

我們高度透明且嚴謹的調查方法，結合與關鍵相關人員的直接互動以及有針對性的第二手資料的整合，能夠得出令人信服的商業見解。

調查方法部分描述了收集、檢驗和整合來自眾多相關人員的定性和定量資訊的系統方法，以便進行嚴格且可重複的分析。

策略性結論闡明了檢查室必須應對的基本運作和臨床挑戰。

這項結論整合了本研究關於診斷策略、營運韌性和臨床影響的核心意義，強調了整個檢查室網路需要積極主動的領導。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：獸醫參考實驗室市場：依動物類型分類

  • 大型動物
    • 牛
    • 馬
  • 小型伴侶動物
    • 貓
    • 狗

第9章 依檢測類型分類的獸醫參考實驗室市場

  • 微生物學
  • 分子診斷
  • 病理
  • 血清學

第10章：獸醫參考實驗室市場：依技術分類

  • 傳統的
  • 免疫檢測
  • 質譜分析
  • 分子

第11章檢體類型分類的獸醫參考實驗室市場

  • 血
  • 屎
  • 棉花棒
  • 組織
  • 尿

第12章 獸醫參考實驗室市場：依最終用戶分類

  • 學術機構
  • 商業的
  • 政府

第13章 獸醫參考實驗室市場：依疾病類型分類

  • 遺傳性疾病
  • 內分泌
  • 感染疾病
    • 細菌
    • 真菌
    • 寄生
    • 病毒性的
  • 代謝性疾病

第14章 獸醫參考實驗室市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 獸醫參考實驗室市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 獸醫參考實驗室市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國獸醫參考實驗室市場

第18章：中國獸醫參考實驗室市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Covetrus, Inc.
  • Eurofins Scientific SE
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • LABOKLIN Laboratory for Clinical Diagnostics GmbH & Co. KG
  • Mars, Incorporated
  • Marshfield Labs
  • Neogen Corporation
  • Protatek Reference Laboratory
  • SYNLAB International GmbH
  • Thermo Fisher Scientific Inc.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-374DB5A06893

The Veterinary Reference Laboratory Market was valued at USD 4.76 billion in 2025 and is projected to grow to USD 5.03 billion in 2026, with a CAGR of 7.21%, reaching USD 7.75 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.76 billion
Estimated Year [2026] USD 5.03 billion
Forecast Year [2032] USD 7.75 billion
CAGR (%) 7.21%

A focused introduction that sets the context for how technological advances, regulatory dynamics, and operational pressures are redefining veterinary diagnostic laboratory priorities

The introduction frames a rapidly evolving veterinary diagnostic landscape where technological innovation, shifting regulatory priorities, and changing patterns of animal health converge to reshape laboratory operations and clinical decision making.

Across veterinary practice and public health functions, diagnostics are increasingly central to evidence-based care. Laboratories are adopting high-sensitivity molecular assays alongside more established immunoassays and culture-based techniques to meet clinician demands for faster, more precise results. At the same time, resource constraints and supply chain complexity challenge routine testing throughput. This introductory overview sets the stage for a focused examination of how diagnostic pathways are being reconfigured, how stakeholders are adapting laboratory workflows, and how diagnostic data are being integrated into disease surveillance and preventive care programs. It also highlights the interplay between clinical needs, laboratory capabilities, and external pressures that create both opportunities and operational stress points for veterinary reference laboratories.

Subsequent sections build from this foundation to unpack structural market dynamics, regulatory and trade impacts, segmentation-driven insights, regional patterns, competitive behaviors, and practical recommendations for leaders seeking to navigate near-term disruptions while positioning their organizations for sustained clinical relevance and operational resilience.

An authoritative analysis of the converging technological, regulatory, and supply chain forces that are accelerating structural change across veterinary diagnostic services

This section examines transformative shifts reshaping veterinary diagnostic services, emphasizing technological progress, policy change, and evolving stakeholder expectations that together accelerate the sector's maturation.

Molecular diagnostics have moved beyond niche applications to become a core pillar of clinical testing, enabling pathogen-specific identification, resistance profiling, and outbreak tracing with unprecedented speed. Concurrently, advances in mass spectrometry and high-throughput immunoassays have expanded the laboratory toolbox for metabolic and hormonal assessments. Regulatory frameworks are adapting to these technologies with updated validation pathways and quality requirements that drive standardization but also increase compliance complexity. At the systems level, digital integration of diagnostic results into practice management and epidemiological platforms is changing the cadence of clinical decision making and supporting population-level surveillance. Moreover, procurement strategies are shifting toward resilient supply chains, with buyers favoring multi-supplier approaches and local manufacturing partnerships to mitigate cross-border disruptions. Taken together, these forces are accelerating consolidation among service providers while opening space for specialized laboratories and technology integrators to capture new clinical niches. The net effect is a more sophisticated, interconnected diagnostic ecosystem that rewards operational excellence, data governance, and strategic alignment with clinician needs.

A detailed review of how recent tariff adjustments in the United States are reshaping procurement, supply chain resilience, and operational planning for diagnostic laboratories

This analysis explores the cumulative effects of recent tariff changes in the United States on veterinary diagnostic operations, supply chains, and procurement strategies while preserving a balanced view of operational realities and mitigation approaches.

Tariff shifts have introduced cost pressure across both consumables and capital equipment that support routine and advanced diagnostic modalities. Laboratories have responded by re-evaluating supplier portfolios, negotiating longer-term contracts, and implementing inventory optimization measures to reduce exposure to price volatility. In parallel, some organizations are adjusting test menus and prioritizing in-house development of reagents and protocols to reduce dependency on imported inputs. For equipment acquisitions, procurement teams are increasingly factoring total cost of ownership, including tariff risk and servicing logistics, into capital justification models. Regulatory compliance considerations complicate supplier substitution, encouraging a methodical approach to validation and cross-reactivity testing when alternatives are introduced. Importantly, tariff-induced friction has also incentivized regional sourcing and strategic partnerships with domestic manufacturers willing to co-develop bespoke solutions. In this environment, laboratory leaders must balance short-term cost containment with long-term investments that preserve clinical capabilities and service reliability, recognizing that operational continuity remains essential for animal health care and public health surveillance.

A comprehensive segmentation-driven perspective that links animal categories, diagnostic modalities, technology platforms, end-user needs, disease focuses, and specimen types to laboratory strategy

Segmentation-driven insight reveals how diagnostic demand and laboratory design vary by animal category, test modality, technology platform, end-user type, disease focus, and sample stream, offering a granular map for portfolio and capability planning.

Based on animal type, analytical pathways diverge between Large Animals, which prioritize production and herd health considerations and are studied across Cattle and Horses, and Small Companion Animals, which prioritize individual clinical outcomes and are studied across Cats and Dogs. Based on test type, laboratory services span Microbiology, Molecular Diagnostics, Pathology, and Serology, each with distinct workflow, turnaround time, and quality control imperatives. Based on technology, choices range across Conventional methods, Immunoassay platforms, Mass Spectrometry approaches, and Molecular tools, shaping capital needs and staffing competencies. Based on end user, demand originates from Academic institutions, Commercial practices, and Government laboratories, each bringing different expectations for reporting, validation, and research collaboration. Based on disease type, diagnostics address Genetic Disorders, Hormonal conditions, Infectious Diseases, and Metabolic issues, with Infectious Diseases further studied across Bacterial, Fungal, Parasitic, and Viral categories that imply differing sample handling and biosafety standards. Based on sample type, analytical pipelines are calibrated for Blood, Feces, Swabs, Tissue, and Urine, with pre-analytic controls and transport logistics tailored to preserve analyte integrity. Integrating these segmentation lenses enables laboratory leaders to align test menus, instrument footprints, staffing models, and client engagement strategies with clinical demand and operational constraints.

A nuanced regional analysis highlighting how regulatory diversity, clinical adoption patterns, and supply chain structures uniquely shape laboratory operations across global territories

Regional patterns demonstrate distinct regulatory, supply, and clinical practice contexts that influence laboratory operations and strategic positioning across global markets.

In the Americas, diagnostic networks are increasingly consolidated, with a strong emphasis on integrated laboratory information systems and partnerships between clinical practices and centralized reference services; this region often leads in clinical adoption of advanced molecular assays and rapid-response capabilities. In Europe, Middle East & Africa, regulatory harmonization efforts and diverse public health priorities create a mosaic of laboratory requirements, where multilingual reporting, cross-border collaboration, and variable infrastructure levels demand flexible service models. In the Asia-Pacific region, rapid growth in pet ownership and intensifying livestock production are driving demand for scalable diagnostic solutions, while local manufacturing and innovative distribution channels are reshaping procurement dynamics. Each regional context carries its own talent pool considerations, reimbursement norms, and logistical challenges, suggesting that a one-size-fits-all approach to service design is likely to underperform. Instead, tailored regional strategies that account for regulatory timing, supply chain topology, and clinician expectations will better support sustainable expansion and quality outcomes.

An insightful overview of the strategic postures adopted by industry participants, from vertically integrated platforms to specialist service providers and collaborative innovation models

Competitive behaviors among leading companies illustrate how strategic choices around vertical integration, service breadth, and partnership models create differentiated value propositions in the diagnostic ecosystem.

Some firms are concentrating on building comprehensive end-to-end offerings that combine proprietary assays, instrument platforms, and managed services to create stickier customer relationships and predictable revenue streams. Others pursue a modular approach, focusing on specialty testing or technology-enabled services that integrate with third-party laboratory information systems to deliver flexibility for clinicians. Strategic alliances with academic centers and government programs continue to be important channels for validation studies and product adoption, particularly for novel molecular and genomic applications. Investment in quality systems, accreditation, and transparent clinical performance data serves as a key trust signal for clients that demand rigorous evidence of diagnostic reliability. Additionally, companies are increasingly leveraging data analytics and remote monitoring to offer value-added services such as test utilization reviews and population health insights. This competitive heterogeneity creates opportunities for both consolidation and niche specialization, with successful organizations combining technical excellence with strong client engagement and operational reliability.

Action-oriented guidance for laboratory leadership focused on workforce agility, procurement resilience, modular technology adoption, and evidence-driven partnerships to secure long-term operational strength

Actionable recommendations guide laboratory executives and industry leaders on prioritizing investments, workforce development, and supplier strategies to strengthen resilience and clinical relevance.

Leaders should invest in cross-trained laboratory personnel who can operate molecular instruments, mass spectrometers, and immunoassay platforms while maintaining strong quality assurance practices; such capability reduces bottlenecks and enhances flexibility during demand surges. Procurement strategies should emphasize supplier diversification, strategic stocking of critical reagents, and collaborative agreements with local manufacturers to reduce tariff and logistics exposure. From a technology standpoint, adopting modular, interoperable systems and standardized data exchange protocols improves scalability and eases integration with clinical practice management tools. Strategic partnerships with academic centers and public health agencies can accelerate validation pathways and expand the clinical evidence base for new assays. Finally, governance frameworks that prioritize data integrity, client communication, and transparent performance metrics will help build trust with clinicians and regulatory bodies, supporting sustained laboratory relevance amid evolving clinical and policy expectations.

A transparent and rigorous research methodology combining primary stakeholder engagement and targeted secondary evidence synthesis to produce defensible operational insights

The research methodology section describes the structured approach used to gather, validate, and synthesize qualitative and quantitative inputs from a broad range of stakeholders for a rigorous, reproducible analysis.

Primary research included in-depth interviews and structured consultations with laboratory directors, clinicians, procurement specialists, and regulatory advisors to capture frontline experience with diagnostic workflows, technology adoption, and supply chain challenges. Secondary sources comprised peer-reviewed literature, regulatory guidance documents, and industry reports to provide contextual grounding and to triangulate primary insights. Data synthesis employed thematic analysis to identify cross-cutting patterns and causal linkages, while validation rounds with subject-matter experts ensured that findings were operationally relevant and technically accurate. Attention was given to transparency in assumptions and to documenting methodological limitations, particularly where regional data heterogeneity required careful interpretation. The result is a defensible, practice-focused body of work that supports strategic decision making without overstating precision in areas where data are fragmented or rapidly evolving.

A strategic conclusion that crystallizes the essential operational and clinical imperatives laboratories must adopt to remain resilient, credible, and service-focused in a changing environment

The conclusion synthesizes the study's core implications for diagnostic strategy, operational resilience, and clinical impact, reinforcing the imperative for proactive leadership across laboratory networks.

Diagnostic services sit at the intersection of animal health, public health surveillance, and clinical care, and the sector's trajectory is shaped by technological innovation, regulatory evolution, and supply chain dynamics. Organizations that align capabilities with segmentation realities-matching test menus and platforms to animal type, disease focus, and sample workflows-are better positioned to deliver timely, actionable results. Strategic investments in workforce skills, interoperable technologies, and diversified procurement reduce operational fragility and enable laboratories to respond to episodic surges or supply disruptions. Collaborative relationships with academic, commercial, and governmental partners can accelerate method validation and broaden the evidence base for new assays. In closing, the path to sustained relevance depends on deliberate, evidence-based choices that balance near-term continuity with long-term capability building, ensuring that diagnostic services remain a reliable foundation for clinical decision making and disease prevention.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Reference Laboratory Market, by Animal Type

  • 8.1. Large Animals
    • 8.1.1. Cattle
    • 8.1.2. Horses
  • 8.2. Small Companion Animals
    • 8.2.1. Cats
    • 8.2.2. Dogs

9. Veterinary Reference Laboratory Market, by Test Type

  • 9.1. Microbiology
  • 9.2. Molecular Diagnostics
  • 9.3. Pathology
  • 9.4. Serology

10. Veterinary Reference Laboratory Market, by Technology

  • 10.1. Conventional
  • 10.2. Immunoassay
  • 10.3. Mass Spec
  • 10.4. Molecular

11. Veterinary Reference Laboratory Market, by Sample Type

  • 11.1. Blood
  • 11.2. Feces
  • 11.3. Swabs
  • 11.4. Tissue
  • 11.5. Urine

12. Veterinary Reference Laboratory Market, by End User

  • 12.1. Academic
  • 12.2. Commercial
  • 12.3. Government

13. Veterinary Reference Laboratory Market, by Disease Type

  • 13.1. Genetic Disorders
  • 13.2. Hormonal
  • 13.3. Infectious Diseases
    • 13.3.1. Bacterial
    • 13.3.2. Fungal
    • 13.3.3. Parasitic
    • 13.3.4. Viral
  • 13.4. Metabolic

14. Veterinary Reference Laboratory Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Reference Laboratory Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Reference Laboratory Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Veterinary Reference Laboratory Market

18. China Veterinary Reference Laboratory Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Covetrus, Inc.
  • 19.6. Eurofins Scientific S.E.
  • 19.7. Heska Corporation
  • 19.8. IDEXX Laboratories, Inc.
  • 19.9. LABOKLIN Laboratory for Clinical Diagnostics GmbH & Co. KG
  • 19.10. Mars, Incorporated
  • 19.11. Marshfield Labs
  • 19.12. Neogen Corporation
  • 19.13. Protatek Reference Laboratory
  • 19.14. SYNLAB International GmbH
  • 19.15. Thermo Fisher Scientific Inc.
  • 19.16. Virbac S.A.
  • 19.17. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY REFERENCE LABORATORY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MASS SPEC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FECES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SWABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY HORMONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY METABOLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 193. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 196. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 223. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 226. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 233. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 237. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. NATO VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL VETERINARY REFERENCE LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SMALL COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA VETERINARY REFERENCE LABORATORY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)